Acetylcysteine 100mg/mL, 200mg/mL; soln for inhalation; preservative-free. See literature for administration of aerosol. Nebulization-face mask, mouth piece, tracheostomy: 1–10mL of 20% soln or 2–20mL ...
SCHAUMBURG, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA, LLC today announced the launch of Acetylcysteine Solution, USP, 20% 30 mL vial for inhalation (mucolytic agent) or oral administration ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA announced today it has launched for immediate availability Acetylcysteine Solution, USP, 20% 4 mL vial for inhalation (mucolytic agent) or oral ...
After 12 weeks of nebulized NAC, patients’ mean phlegm scores, as measured by the COPD assessment test, significantly decreased from 3.47 at baseline to 2.62. N-acetylcysteine (NAC) nebulizer therapy ...
Ben Venue Laboratories has initiated a nationwide voluntary recall to the patient level of a single lot of acetylcysteine solution 10% (30 mL vials) after discovering a single visible glass particle ...
FOR IMMEDIATE RELEASE - February 14, 2014 - Ben Venue Laboratories, Inc. today issued a nationwide voluntary product recall: Acetylcysteine Solution 10%, USP, (Manufactured for Roxane Laboratories, ...
Acetylcysteine Solution, USP, (Manufactured for Roxane Laboratories, Inc.) 20%, 30 mL per vial - NDC #0054-3026-02 - Lot 1877093 - Exp. Date June 2013 This voluntary recall was initiated on December ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback